REFERENCES

Ariyanayagam MR, Fairlamb AH 1997. Diamine auxotrophy may be a universal feature of Trypanosoma cruzi epi-mastigotes. Mol Biochem Parasitol 84: 111-121.

Augustyns K, Amssoms K, Yamani A, Rajan, P K, Haemers A 2001. Trypanothione as a target in the design of anti-trypanosomal and antileishmanial agents. Curr Pharm Des 7: 1117-1141.

Bond CS, Zhang Y, Berriman M, Cunningham ML, Fairlamb AH, Hunter WN 1999. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with try-panothione, and the structure-based discovery of new natural product inhibitors. Structure Fold Des 7: 81-89.

Borges A, Cunningham ML, Tovar J, Fairlamb AH 1995. Site-directed mutagenesis of the redox-active cysteines of Trypanosoma cruzi trypanothione reductase. Eur J Biochem 228: 745-752.

Cunningham ML, Fairlamb AH 1995. Trypanothione reductase from Leishmania donovani. Purification, charac-terisation and inhibition by trivalent antimonials. Eur J Biochem 230: 460-468.

Fairlamb AH 1999. Future prospects for the chemotherapy of Chagas' disease. Medicina (B Aires) 59: 179-187.

Fairlamb AH, Cerami A 1992. Metabolism and functions of trypanothione in the Kinetoplastida. Annu Rev Microbiol 46: 695-729.

Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A 1985. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 227: 1485-1487.

Flohe L, Hecht HJ, Steinert P 1999. Glutathione and trypa-nothione in parasitic hydroperoxide metabolism. Free Radic Biol Med 27: 966-984.

Fournet A, Inchausti A, Yaluff G, Rojas De Arias A, Guinaudeau H, Bruneton J, Breidenbach MA, Karplus PA, Faerman CH 1998. Trypanocidal bisbenzylisoquinoline alkaloids are inhibitors of trypanothione reductase. J Enzyme Inhib 13: 1-9.

Fournet A, Rojas de Arias A, Ferreira ME, Nakayama H, Torres de Ortiz S, Schinini A, Samudio M, Vera de Bilbao N, Lavault M, Bonte F 2000. Efficacy of the bisben-zylisoquinoline alkaloids in acute and chronic Trypanosoma cruzi murine model. Int J Antimicrob Agents 13: 189-195.

Gallwitz H, Bonse S, Martinez-Cruz A, Schlichting I, Schumacher K, Krauth-Siegel RL 1999. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: crystallographic, kinetic, and spectroscopic studies. J Med Chem 42: 364-372.

Hamilton CJ, Saravanamuthu A, Eggleston IM, Fairlamb AH 2003. Ellman's reagent-mediated regeneration of try-panothione in situ: Substrate economic microplate and time-dependent inhibition assays for trypanothione reductase. Biochem J 369: 529-537.

Henderson GB, Ulrich P, Fairlamb AH, Rosenberg I, Pereira M, Sela M, Cerami A 1988. "Subversive" substrates for the enzyme trypanothione disulfide reductase: alternative approach to chemotherapy of Chagas disease. Proc Natl Acad Sci USA 85: 5374-5378.

Iribarne F, Paulino M, Aguilera S, Murphy M, Tapia O 2002. Docking and molecular dynamics studies at trypanothione reductase and glutathione reductase active sites. J Mol Model (Online) 8: 173-183.

Jockers-Scherubl MC, Schirmer RH, Krauth-Siegel RL 1989. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds. Eur J Biochem 180: 267-272.

Krieger S, Schwarz W, Ariyanayagam MR, Fairlamb AH, Krauth-Siegel RL, Clayton C 2000. Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress. Mol Microbiol 35: 542-552.

Ponasik JA, Strickland C, Faerman C, Savvides S, Karplus PA, Ganem B 1995. Kukoamine A and other hydrophobic acylpolyamines: potent and selective inhibitors of Crithidia fasciculata trypanothione reductase. Biochem J 311: 371-375.

Salmon-Chemin L, Buisine E, Yardley V, Kohler S, Debreu MA, Landry V, Sergheraert C, Croft SL, Krauth-Siegel RL, Davioud-Charvet E 2001. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J Med Chem 44: 548-565.

Salmon-Chemin L, Lemaire A, De Freitas S, Deprez B, Sergheraert C, Davioud-Charvet E 2000. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi. Bioorg Med Chem Lett 10: 631-635.

Schmidt A, Krauth-Siegel RL 2002. Enzymes of the try-panothione metabolism as targets for antitrypanosomal drug development. Curr Top Med Chem 2: 1239-1259.

Tovar J, Cunningham ML, Smith AC, Croft SL and Fairlamb AH 1998. Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a transdominant mutant homologue: effect on parasite
intracellular survival. Proc Natl Acad Sci USA 95: 5311-5316.

Werbovetz KA 2000. Target-based drug discovery for malaria, leishmaniasis, and trypanosomiasis. Curr Med Chem 7:
835-860.

Worthington DJ, Rosemeyer MA 1974. Human glutathione reductase: purification of the crystalline enzyme from erythrocytes. Eur J Biochem 48: 167-177.

Zani CL, Chiari E, Krettli AU, Murta SM, Cunningham ML, Fairlamb AH, Romanha AJ 1997. Anti-plasmodial and anti-trypanosomal activity of synthetic naphtho[2,3-b]thiopen-4,9-quinones. Bioorg Med Chem 5: 2185-2192.